Allergy-Related White Blood Cells May Be Used Effectively Against Cancer

In cancer, every day the importance of the immune system becomes clearer. Recently, immunotherapies, T cells alongside other immune cells, have become targets. In this context, in January 2018, Cancer Immunology published a study discovering that eosinophils, immune cells responsible for allergy, could be used effectively to destroy cancer cells.

Above, the types of blood cell can be seen. An eosinophil is a type of granular leukocyte.
The research was conducted at Tel Aviv University in Israel. Eosinophils are white blood cells involved in immune responses to parasites and responsible for damage during allergic reactions. Researchers tested their anticancer effects in colorectal cancer mouse models. As the intestine contains the most eosinophils, intestinal cancer models were used.
According to the research results;
- Eosinophils showed anticancer effects, directly destroying cancer cells independently of T cells.
- Their anticancer effects increased when activated with interferon gamma (IFN-γ).
- Tumor samples from 275 cancer patients were also compared for eosinophil count and disease condition and stage. Higher counts were associated with lower disease severity.
What does this study mean for us?
- A new cancer immunotherapy target was discovered. Like T lymphocytes, eosinophils can potentially destroy cancer cells effectively.
- Using eosinophils together with T cells may provide effective cancer treatment.
- It is important to emphasize that this study remains preclinical. Human clinical trials are needed to confirm this.
Sources
Activated Eosinophils Exert Antitumorigenic Activities in Colorectal Cancer.
Cancer Immunology Research, 21 January 2019.
Was this article helpful?
Your feedback helps us improve our content.





Reader comments
Share your comment
Your name and comment are published only after administrator approval. Your email address is never shown to visitors.
Be the first to comment.